# Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease

> **NCT03346954** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 33 (actual)

## Conditions studied

- Cushing's Disease

## Interventions

- **OTHER:** [11C]-Methionine PET/MRI

## Key facts

- **NCT ID:** NCT03346954
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-11
- **Primary completion:** 2019-06-11
- **Final completion:** 2020-08-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346954, "Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03346954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*